3-Acetamido-piperidon | 98336-92-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-Acetamido-piperidon
• 英文别名: DL-α-Acetamino-piperidon；N-(2-oxo-[3]piperidyl)-acetamide；N-(2-Oxo-[3]piperidyl)-acetamid；N-(2-oxopiperidin-3-yl)acetamide
• CAS: 98336-92-6
• 化学式: C₇H₁₂N₂O₂
• 分子量: 156.184
• InChiKey: NXGOJJKVSDOOGU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  盐酸 、 3-Acetamido-piperidon 生成 alkaline earth salt of/the/ methylsulfuric acid
  参考文献：
  名称：

  Bergmann; Koester, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1926, vol. 159, p. 188

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 2-(甲基氨基)乙酸乙酯 作用下， 生成 3-Acetamido-piperidon
  参考文献：
  名称：

  Bergmann; Zervas, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1927, vol. 172, p. 282

  摘要：

  DOI：

文献信息

• [EN] COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS<br/>[FR] COMPOSÉS UTILES POUR LE TRAITEMENT DE TROUBLES NEURODÉGÉNÉRATIFS
  申请人：SATORI PHARMACEUTICALS INC

  公开号：WO2011109657A1

  公开（公告）日：2011-09-09

  As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.

  如本文所述，本发明提供了用于治疗或减轻神经退行性疾病严重程度的化合物。本发明还提供了治疗或减轻此类疾病严重程度的方法，其中所述方法包括向患者施用本发明的化合物或其组合物。该方法适用于治疗或减轻例如阿尔茨海默病等疾病的严重程度。
• Method for preparation of sulphostin and its analogue or intermediates thereof
  申请人：Nagai Masashi

  公开号：US20050020834A1

  公开（公告）日：2005-01-27

  A method for preparing a compound represented by the following general formula (5) where, n is an integer of 0 to 3; and Y represents a protecting group for an amino group, the method including the steps of reacting a compound represented by the following general formula (3) where n and Y are as described above, with a silylating agent, and subsequently reacting it with P (═O) T 3 , where T represents a halogen atom, and further with ammonia. A method for preparing an optically active intermediate of sulphostin or an analogue thereof, which is an optically active amine salt of an optically active compound represented by the following general formula (8) where n is an integer of 0 to 3; Y represents a protecting group for the amino group; and each configuration at C* and P* may be the same or different and indicates S or R, the method including reacting a compound represented by the following general formula (7) where n and Y are as described above; and the configuration of C* indicates either of S or R, with an optically active amine, and resolving the formed diastereomeric salt by fractional crystallization.

  以下是一个制备以下通用式（5）所表示的化合物的方法，其中n为0到3的整数；Y表示氨基保护基。该方法包括以下步骤：将以下通用式（3）所表示的化合物与硅基化试剂反应，然后再与P（═O）T3（其中T表示卤素原子）反应，最后再与氨反应。 以下是制备sulphostin或其类似物的光学活性中间体的方法，该中间体是以下通用式（8）所表示的光学活性化合物的光学活性胺盐，其中n为0到3的整数；Y表示氨基保护基；C*和P*的每个构型可以相同也可以不同，并表示S或R。该方法包括将以下通用式（7）所表示的化合物与光学活性胺反应，并通过分数结晶分离形成的对映异构体盐。
• Selective Synthesis of Lysine Peptides and the Prebiotically Plausible Synthesis of Catalytically Active Diaminopropionic Acid Peptide Nitriles in Water
  作者：Benjamin Thoma、Matthew W. Powner

  DOI：10.1021/jacs.2c12497

  日期：2023.2.8

  Why life encodes specific proteinogenic amino acids remains an unsolved problem, but a non-enzymatic synthesis that recapitulates biology’s universal strategy of stepwise N-to-C terminal peptide growth may hold the key to this selection. Lysine is an important proteinogenic amino acid that, despite its essential structural, catalytic, and functional roles in biochemistry, has widely been assumed to

  为什么生命编码特定的蛋白质氨基酸仍然是一个未解决的问题，但是一种非酶促合成概括了生物学逐步从N到C的普遍策略末端肽的生长可能是这一选择的关键。赖氨酸是一种重要的蛋白质氨基酸，尽管它在生物化学中具有重要的结构、催化和功能作用，但已被广泛认为是遗传密码的后期添加。在这里，我们证明赖氨酸硫代酸在中性水中与氨基腈偶联，以接近定量的产量提供肽，而非蛋白原赖氨酸同系物、鸟氨酸和二氨基丁酸由于快速和定量环化不可逆地阻断肽合成而不能形成肽。我们首次证明鸟氨酸内酰胺化在（非酶促）N -to- C过程中提供赖氨酸和鸟氨酸的绝对差异-末端肽连接。我们还证明最短的赖氨酸同源物二氨基丙酸可进行有效的肽连接。这促使我们发现了一种高产益生元合成二氨基丙酸残基的方法，通过肽腈修饰，通过向脱氢丙氨酸腈中添加氨。通过手头的这种合成，我们随后发现二氨基丙酰基残基的低碱度促进了中性水中有效的仿生亚胺催化。我们的结果表明，通过肽腈修饰合成的二氨基丙酸，
• PROCESSES FOR PREPARATION OF SULPHOSTIN AND ITS ANALOGUES OR INTERMEDIATES THEREOF
  申请人：Nippon Kayaku Kabushiki Kaisha

  公开号：EP1457494A1

  公开（公告）日：2004-09-15

  A method for preparing a compound represented by the following general formula (5)    where, n is an integer of 0 to 3; and Y represents a protecting group for an amino group, the method including the steps of reacting a compound represented by the following general formula (3)    where n and Y are as described above, with a silylating agent, and subsequently reacting it with P (=O) T3, where T represents a halogen atom, and further with ammonia. A method for preparing an optically active intermediate of sulphostin or an analogue thereof, which is an optically active amine salt of an optically active compound represented by the following general formula (8) where n is an integer of 0 to 3; Y represents a protecting group for the amino group; and each configuration at C* and P* may be the same or different and indicates S or R, the method including reacting a compound represented by the following general formula (7) where n and Y are as described above; and the configuration of C* indicates either of S or R, with an optically active amine, and resolving the formed diastereomeric salt by fractional crystallization.

  一种制备由以下通式(5)代表的化合物的方法 其中，n 是 0 至 3 的整数；Y 代表氨基的保护基团，该方法包括以下步骤：使下一通式（3）所代表的化合物与硅烷化剂反应，其中 n 和 Y 如上所述。 其中，n 和 Y 如上所述，与硅烷化剂反应，然后与 P (=O) T3 反应，其中 T 代表卤素原子，再与氨反应。 一种制备舒磷定或其类似物的光学活性中间体的方法，该光学活性中间体是由下 列通式（8）代表的光学活性化合物的光学活性胺盐 其中 n 是 0 至 3 的整数；Y 代表氨基的保护基团；C* 和 P* 的每个构型可以相同或不同，并表示 S 或 R，该方法包括使下式通式（7）所代表的化合物反应 其中 n 和 Y 如上所述；C* 的构型表示 S 或 R，与光学活性胺反应，并通过分馏结晶分 解所形成的非对映异构盐。
• Bergmann; Zervas, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1928, vol. 173, p. 80
  作者：Bergmann、Zervas

  DOI：——

  日期：——